Aurinia Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05156V1022
USD
14.53
6.39 (78.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
73.47
70.01
62.47
59.87
67.77
57.19
50.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
73.47
70.01
62.47
59.87
67.77
57.19
50.30
Raw Material Cost
8.18
7.12
8.57
5.55
6.04
8.91
7.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
18.79
16.59
10.04
26.90
26.58
27.28
30.52
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.10
1.12
1.07
1.15
1.21
1.20
1.28
Selling and Distribution Expenses
26.18
26.02
20.34
37.03
42.37
44.93
47.70
Other Expenses
-1.15
-1.03
-0.54
-1.99
-2.47
-2.44
-2.63
Total Expenditure (Excl Depreciation)
42.79
40.57
34.66
50.69
51.45
57.92
61.00
Operating Profit (PBDIT) excl Other Income
30.7
29.4
27.799999999999997
9.200000000000001
16.299999999999997
-0.7000000000000001
-10.700000000000001
Other Income
2.39
-6.06
-0.86
8.49
-0.31
4.48
8.65
Operating Profit (PBDIT)
37.93
28.25
31.81
22.53
20.91
8.59
2.80
Interest
1.10
1.12
1.07
1.15
1.21
1.20
1.28
Exceptional Items
0.00
-0.11
-1.53
-15.35
0.00
-1.07
-6.68
Gross Profit (PBDT)
65.29
62.89
53.89
54.32
61.74
48.28
42.55
Depreciation
4.87
4.86
4.86
4.86
4.89
4.84
4.85
Profit Before Tax
31.96
22.16
24.35
1.17
14.81
1.48
-10.01
Tax
0.41
0.64
1.01
-0.26
0.46
0.76
0.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
31.55
21.51
23.34
1.43
14.35
0.72
-10.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
31.55
21.51
23.34
1.43
14.35
0.72
-10.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
31.55
21.51
23.34
1.43
14.35
0.72
-10.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
365.77
335.30
350.19
377.48
388.00
364.62
359.48
Earnings per share (EPS)
0.23
0.16
0.16
0.01
0.1
0.01
-0.07
Diluted Earnings per share
0.23
0.16
0.16
0.01
0.1
0.01
-0.07
Operating Profit Margin (Excl OI)
41.75%
42.06%
44.52%
15.33%
24.08%
-1.28%
-21.26%
Gross Profit Margin
50.13%
38.6%
46.75%
10.08%
29.07%
11.05%
-10.26%
PAT Margin
42.95%
30.73%
37.37%
2.39%
21.17%
1.26%
-21.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 5.00% vs 12.00% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 46.98% vs -7.73% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 3.50% vs 4.89% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Aurinia Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
73.47
59.95
13.52
22.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
73.47
59.95
13.52
22.55%
Raw Material Cost
8.18
62.90
-54.72
-87.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
18.79
0.00
18.79
Power Cost
0
0
0.00
Manufacturing Expenses
1.10
0.00
1.10
Selling and Distribution Expenses
26.18
31.46
-5.28
-16.78%
Other Expenses
-1.15
7.94
-9.09
-114.48%
Total Expenditure (Excl Depreciation)
42.79
173.73
-130.94
-75.37%
Operating Profit (PBDIT) excl Other Income
30.67
-113.77
144.44
126.96%
Other Income
2.39
4.10
-1.71
-41.71%
Operating Profit (PBDIT)
37.93
-97.73
135.66
138.81%
Interest
1.10
0.00
1.10
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
65.29
-2.95
68.24
2,313.22%
Depreciation
4.87
11.94
-7.07
-59.21%
Profit Before Tax
31.96
-109.67
141.63
129.14%
Tax
0.41
1.99
-1.58
-79.40%
Provisions and contingencies
0
0
0.00
Profit After Tax
31.55
-111.66
143.21
128.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
31.55
-111.66
143.21
128.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
31.55
-111.66
143.21
128.26%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
365.77
698.49
-332.72
-47.63%
Earnings per share (EPS)
0.23
-0.33
0.56
169.70%
Diluted Earnings per share
0.23
-0.33
0.56
169.70%
Operating Profit Margin (Excl OI)
41.75%
-189.78%
0.00
231.53%
Gross Profit Margin
50.13%
-163.02%
0.00
213.15%
PAT Margin
42.95%
-186.25%
0.00
229.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.35 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.00% vs 12.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 8.41% vs 24.40% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.16 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 46.98% vs -7.73% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 119.44% vs 207.46% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.55 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.50% vs 4.89% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 67.45% vs 358.54% in Sep 2024

Quarterly - Interest
Interest 0.11 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -8.33% vs -14.29% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.75%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024